BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7518666)

  • 1. Aggressive multimodality therapy for malignant pleural mesothelioma.
    Rice TW; Adelstein DJ; Kirby TJ; Saltarelli MG; Murthy SR; Van Kirk MA; Wiedemann HP; Weick JK
    Ann Thorac Surg; 1994 Jul; 58(1):24-9. PubMed ID: 7518666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
    Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
    J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.
    Sauter ER; Langer C; Coia LR; Goldberg M; Keller SM
    J Surg Oncol; 1995 Oct; 60(2):100-5. PubMed ID: 7564374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
    Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
    Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-modality therapy in malignant pleural mesothelioma: a phase II study.
    Lucchi M; Chella A; Melfi F; Dini P; Tibaldi C; Fontanini G; Mussi A
    J Thorac Oncol; 2007 Mar; 2(3):237-42. PubMed ID: 17410047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Belcher E; Cane P; Landau D; Steele J; Taylor H; Spicer J
    J Thorac Oncol; 2011 Oct; 6(10):1746-52. PubMed ID: 21876457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study.
    Ratto GB; Civalleri D; Esposito M; Spessa E; Alloisio A; De Cian F; Vannozzi MO
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):759-65. PubMed ID: 10096972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
    de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
    Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
    Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
    Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.
    Kasseyet S; Astoul P; Boutin C
    Cancer; 1999 Apr; 85(8):1740-9. PubMed ID: 10223568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
    Richards WG; Zellos L; Bueno R; Jaklitsch MT; Jänne PA; Chirieac LR; Yeap BY; Dekkers RJ; Hartigan PM; Capalbo L; Sugarbaker DJ
    J Clin Oncol; 2006 Apr; 24(10):1561-7. PubMed ID: 16575008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Rusch VW
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):534-5. PubMed ID: 17267238
    [No Abstract]   [Full Text] [Related]  

  • 19. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
    Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
    Lee TT; Everett DL; Shu HK; Jahan TM; Roach M; Speight JL; Cameron RB; Phillips TL; Chan A; Jablons DM
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1183-9. PubMed ID: 12447185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.